InvestLog
RADX Radiopharm Theranostics Limited logo

RADX Radiopharm Theranostics Limited

Healthcare
$4.61-0.43%ClosedMarket Cap: $5.9M

As of 2026-05-26

Valuation

P/E (TTM)

—

PEG

—

P/B

1.44

P/S

4.02

EV/EBITDA

-0.35

DCF Value

$-45.95

FCF Yield

-74.7%

Div Yield

0.0%

Margins & Returns

Gross Margin

172.7%

Operating Margin

-402.8%

Net Margin

-364.0%

ROE

-93.1%

ROA

-49.3%

ROIC

-59.9%

Income Statement

Periods shown are fiscal year quarters (may differ from calendar year)

PeriodRevenueGross MarginOperating IncomeNet IncomeEPSDividend
FY null$3.6M1.1%$-38.2M$-38.3M$——
FY null$299.2K100.0%$-36.6M$-47.9M$——
FY null$292.4K100.0%$-34.5M$-34.6M$——
FY null$8.8K100.0%$-19.9M$-30.3M$——